Related Articles

H1N1 vaccine for prevention of pandemic influenza.

Med Lett Drugs Ther. 2009 Oct 5;51(1322):77-8

Authors:

The FDA has licensed 4 new monovalent vaccines for prevention of respiratory illness caused by a new influenza A H1N1 virus that appears to be derived from a swine strain. The 5th vaccine should be licensed soon. All of these vaccines are expected to become available in October. An intranasal formulation is expected in the first week of October.

PMID: 19798010 [PubMed - indexed for MEDLINE]

[Read more →]

Related Articles

A diuretic for initial treatment of hypertension.

Med Lett Drugs Ther. 2009 Feb 9;51(1305):9-10

Authors:

Effective treatment of hypertension can prevent organ damage and death. The choice of drugs for initial treatment continues to be controversial.

PMID: 19197232 [PubMed - indexed for MEDLINE]

[Read more →]

Related Articles

Two new drugs for chronic ITP.

Med Lett Drugs Ther. 2009 Feb 9;51(1305):10-1

Authors:

Romiplostim (Nplate – Amgen), a recombinant fusion protein injected subcutaneously, and eltrombopag (Promacta – GlaxoSmithKline), a non-peptide taken orally, have been approved by the FDA for treatment of chronic immune thrombocytopenic purpura (ITP) refractory to corticosteroids, immunoglobulins and/or splenectomy.

PMID: 19197233 [PubMed - indexed for MEDLINE]

[Read more →]

Related Articles

Long-acting beta-2 agonists in asthma.

Med Lett Drugs Ther. 2009 Jan 12;51(1303):1-2

Authors:

PMID: 19122566 [PubMed - indexed for MEDLINE]

[Read more →]

Related Articles

Influenza vaccine 2008-2009.

Med Lett Drugs Ther. 2008 Oct 6;50(1296):77-9

Authors:

Annual immunization against influenza A and B is the most effective method of preventing infection and has been shown to reduce influenza complications. Changes this year include a vaccine with three new influenza antigens and expanded age criteria to include all children 6 months to 18 years of age. An upcoming issue of The Medical Letter will review drugs for prophylaxis and treatment of influenza.

PMID: 18833032 [PubMed - indexed for MEDLINE]

[Read more →]

Related Articles

Natalizumab (Tysabri) for Crohn’s disease.

Med Lett Drugs Ther. 2008 May 5;50(1285):34-6

Authors:

PMID: 18458669 [PubMed - indexed for MEDLINE]

[Read more →]